NANOREPRO AG (NN6.DE) Stock Fundamental Analysis
Europe - FRA:NN6 - DE0006577109 - Common Stock
1.72 EUR
+0.05 (+3.3%)
Taking everything into account, NN6 scores 5 out of 10 in our fundamental rating. NN6 was compared to 62 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for NN6 as it has an excellent financial health rating, but there are worries on the profitability. NN6 is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
NN6 had negative earnings in the past year.
NN6 had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NN6 reported negative net income in multiple years.
In multiple years NN6 reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of NN6 (-5.26%) is worse than 67.74% of its industry peers.
Looking at the Return On Equity, with a value of -5.39%, NN6 is doing worse than 67.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.26% | ||
| ROE | -5.39% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NN6's Gross Margin of 61.74% is fine compared to the rest of the industry. NN6 outperforms 61.29% of its industry peers.
NN6's Gross Margin has declined in the last couple of years.
NN6 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.75% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.24%
GM growth 5Y-10.7%
2. Health
2.1 Basic Checks
NN6 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NN6 remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NN6 has more shares outstanding
There is no outstanding debt for NN6. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 15.50 indicates that NN6 is not in any danger for bankruptcy at the moment.
NN6 has a Altman-Z score of 15.50. This is amongst the best in the industry. NN6 outperforms 95.16% of its industry peers.
There is no outstanding debt for NN6. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 15.5 |
ROIC/WACCN/A
WACC7.33%
2.3 Liquidity
A Current Ratio of 50.00 indicates that NN6 has no problem at all paying its short term obligations.
NN6's Current ratio of 50.00 is amongst the best of the industry. NN6 outperforms 100.00% of its industry peers.
A Quick Ratio of 46.73 indicates that NN6 has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 46.73, NN6 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 50 | ||
| Quick Ratio | 46.73 |
3. Growth
3.1 Past
NN6 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.76%, which is quite impressive.
Looking at the last year, NN6 shows a very strong growth in Revenue. The Revenue has grown by 40.57%.
Measured over the past years, NN6 shows a very strong growth in Revenue. The Revenue has been growing by 29.69% on average per year.
EPS 1Y (TTM)56.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)40.57%
Revenue growth 3Y-69.83%
Revenue growth 5Y29.69%
Sales Q2Q%50.84%
3.2 Future
The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
NN6 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 104.40% yearly.
EPS Next Y-1%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year232.82%
Revenue Next 2Y104.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NN6. In the last year negative earnings were reported.
Also next year NN6 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NN6 indicates a rather cheap valuation: NN6 is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.34 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as NN6's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.98%, NN6 is a good candidate for dividend investing.
NN6's Dividend Yield is rather good when compared to the industry average which is at 2.23. NN6 pays more dividend than 100.00% of the companies in the same industry.
NN6's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.98% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y41.42%
EPS Next 3YN/A
FRA:NN6 (10/27/2025, 7:00:00 PM)
1.72
+0.05 (+3.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners9.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.19M
Revenue(TTM)4.47M
Net Income(TTM)-2050000
Analysts84
Price Target4.59 (166.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.98% |
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.96 | ||
| P/FCF | 2.34 | ||
| P/OCF | 2.25 | ||
| P/B | 0.58 | ||
| P/tB | 0.64 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.74
FCFY42.82%
OCF(TTM)0.76
OCFY44.44%
SpS0.35
BVpS2.96
TBVpS2.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.26% | ||
| ROE | -5.39% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.75% | ||
| FCFM | 212.53% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.24%
GM growth 5Y-10.7%
F-Score8
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1200% | ||
| Cap/Sales | 8.05% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 50 | ||
| Quick Ratio | 46.73 | ||
| Altman-Z | 15.5 |
F-Score8
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y-1%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.57%
Revenue growth 3Y-69.83%
Revenue growth 5Y29.69%
Sales Q2Q%50.84%
Revenue Next Year232.82%
Revenue Next 2Y104.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y195%
FCF growth 3Y4.97%
FCF growth 5YN/A
OCF growth 1Y198.6%
OCF growth 3Y6.28%
OCF growth 5YN/A
NANOREPRO AG / NN6.DE FAQ
What is the ChartMill fundamental rating of NANOREPRO AG (NN6.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to NN6.DE.
What is the valuation status for NN6 stock?
ChartMill assigns a valuation rating of 2 / 10 to NANOREPRO AG (NN6.DE). This can be considered as Overvalued.
What is the profitability of NN6 stock?
NANOREPRO AG (NN6.DE) has a profitability rating of 1 / 10.
Can you provide the financial health for NN6 stock?
The financial health rating of NANOREPRO AG (NN6.DE) is 9 / 10.